This is a $6,155,378.96 time and materials contract awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. for the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3). The contract, which runs through September 29, 2025, is not set aside. Iqvia, a leading provider of healthcare data, analytics, and related services to federal agencies, will provide data sources to support the FDA's post-market surveillance of biologics. This award is part of a larger $50 million multiple-award Indefinite Delivery Vehicle (IDV) the FDA has with Iqvia for the BEST Initiative, which aims to enhance the agency's ability to monitor the safety and effectiveness of regulated biological products.
Generated 9/28/24, 10:40 AM